Researchers at UC San Diego have discovered that the enzyme MICAL2 accelerates tumor growth in pancreatic cancer by influencing key signaling pathways. This finding points to MICAL2 as a potential tar

Pancreatic cancer kills 50,000 people each year, according to the National Cancer Institute, and there are few effective treatment options for the disease. In a new study, researchers at University of California San Diego School of Medicine have discovered that an enzyme called MICAL2 promotes tumor growth and spread in pancreatic ductal adenocarcinomas (PDAC),

Pancreatic cancer is one of the most lethal malignancies, with nearly 50,000 deaths annually in the United States, according to the National Cancer Institute. Despite advancements in cancer research,